Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Grabowski

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 7, 2009
Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1Gregory A Grabowski, Katherine Kacena, J Alexander Cole, et al.
Human Molecular Genetics|March 7, 2014
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease miceYou-hai Xu, Kui Xu, Ying Sun, et al.
Human Molecular Genetics|May 16, 2008
Neurological deficits and glycosphingolipid accumulation in saposin B deficient miceYing Sun, David P Witte, Huimin Ran, et al.
Human Molecular Genetics|March 1, 2013
Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant miceYing Sun, Matt Zamzow, Huimin Ran, et al.
Plos One|March 31, 2015
Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathologyYing Sun, Jane Florer, Christopher N Mayhew, et al.
Human Molecular Genetics|January 6, 2010
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficitsYing Sun, Benjamin Liou, Huimin Ran, et al.
Human Molecular Genetics|September 23, 2016
Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease miceBenjamin Liou, Yanyan Peng, Ronghua Li, et al.
Molecular Genetics and Metabolism|September 16, 2014
CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findingsThomas A Burrow, Ying Sun, Carlos E Prada, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2016
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher DiseaseJohn Marshall, Ying Sun, Dinesh S Bangari, et al.
Science (New York, N.Y.)|December 20, 2003
Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteinsDapeng Zhou, Carlos Cantu, Yuval Sagiv, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 7, 2009
Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1Gregory A Grabowski, Katherine Kacena, J Alexander Cole, et al.
Human Molecular Genetics|March 7, 2014
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease miceYou-hai Xu, Kui Xu, Ying Sun, et al.
Human Molecular Genetics|May 16, 2008
Neurological deficits and glycosphingolipid accumulation in saposin B deficient miceYing Sun, David P Witte, Huimin Ran, et al.
Human Molecular Genetics|March 1, 2013
Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant miceYing Sun, Matt Zamzow, Huimin Ran, et al.
Plos One|March 31, 2015
Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathologyYing Sun, Jane Florer, Christopher N Mayhew, et al.
Human Molecular Genetics|January 6, 2010
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficitsYing Sun, Benjamin Liou, Huimin Ran, et al.
Human Molecular Genetics|September 23, 2016
Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease miceBenjamin Liou, Yanyan Peng, Ronghua Li, et al.
Molecular Genetics and Metabolism|September 16, 2014
CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findingsThomas A Burrow, Ying Sun, Carlos E Prada, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2016
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher DiseaseJohn Marshall, Ying Sun, Dinesh S Bangari, et al.
Science (New York, N.Y.)|December 20, 2003
Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteinsDapeng Zhou, Carlos Cantu, Yuval Sagiv, et al.
Pageof 13